162 related articles for article (PubMed ID: 34930582)
41. Rationale and methods of the IDOMENEO health outcomes of the peripheral arterial disease revascularisation study in the GermanVasc registry.
Debus ES; Kriston L; Schwaneberg T; Hischke S; Rieß HC; Härter M; Marschall U; Federrath H; Behrendt CA
Vasa; 2018 Oct; 47(6):499-505. PubMed ID: 30113269
[TBL] [Abstract][Full Text] [Related]
42. Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.
Prang KH; Karanatsios B; Verbunt E; Wong HL; Yeung J; Kelaher M; Gibbs P
Contemp Clin Trials; 2022 Aug; 119():106843. PubMed ID: 35792338
[TBL] [Abstract][Full Text] [Related]
43. Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
McGettigan P; Alonso Olmo C; Plueschke K; Castillon M; Nogueras Zondag D; Bahri P; Kurz X; Mol PGM
Drug Saf; 2019 Nov; 42(11):1343-1351. PubMed ID: 31302896
[TBL] [Abstract][Full Text] [Related]
44. Review of the research databases on population-based Registries of Unified electronic Healthcare system of Kazakhstan (UNEHS): Possibilities and limitations for epidemiological research and Real-World Evidence.
Gusmanov A; Zhakhina G; Yerdessov S; Sakko Y; Mussina K; Alimbayev A; Syssoyev D; Sarria-Santamera A; Gaipov A
Int J Med Inform; 2023 Feb; 170():104950. PubMed ID: 36508752
[TBL] [Abstract][Full Text] [Related]
45. The use of real-world data to address questions of patient safety.
Yates M; Bechman K; Galloway J
Rheumatology (Oxford); 2020 Jan; 59(1):26-30. PubMed ID: 31834407
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of Research Accessibility and Data Elements of HIV Registries.
Mayer CS; Williams N; Fung KW; Huser V
Curr HIV Res; 2019; 17(4):258-265. PubMed ID: 31550214
[TBL] [Abstract][Full Text] [Related]
47. Big data and ophthalmic research.
Clark A; Ng JQ; Morlet N; Semmens JB
Surv Ophthalmol; 2016; 61(4):443-65. PubMed ID: 26844660
[TBL] [Abstract][Full Text] [Related]
48. mHealth education interventions in heart failure.
Allida S; Du H; Xu X; Prichard R; Chang S; Hickman LD; Davidson PM; Inglis SC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD011845. PubMed ID: 32613635
[TBL] [Abstract][Full Text] [Related]
49. Categorizing the world of registries.
Drolet BC; Johnson KB
J Biomed Inform; 2008 Dec; 41(6):1009-20. PubMed ID: 18329960
[TBL] [Abstract][Full Text] [Related]
50. The use of hospital registries in orthopaedic surgery.
Ahn H; Court-Brown CM; McQueen MM; Schemitsch EH
J Bone Joint Surg Am; 2009 May; 91 Suppl 3():68-72. PubMed ID: 19411502
[TBL] [Abstract][Full Text] [Related]
51. The Contribution of Cancer Surveillance Toward Real World Evidence in Oncology.
Penberthy L; Rivera DR; Ward K
Semin Radiat Oncol; 2019 Oct; 29(4):318-322. PubMed ID: 31472732
[TBL] [Abstract][Full Text] [Related]
52. A Cardio-Oncology Data Commons: Lessons from Pediatric Oncology.
Mandawat A; Eberly L; Border W
Curr Cardiol Rep; 2019 Sep; 21(10):128. PubMed ID: 31520151
[TBL] [Abstract][Full Text] [Related]
53. Considerations for the use of biochemical laboratory registry data in clinical and public health research.
Obel LM; Adelborg K; Pottegård A; Sørensen HT; Nybo M
J Clin Epidemiol; 2024 Jun; 170():111337. PubMed ID: 38556100
[TBL] [Abstract][Full Text] [Related]
54. Swedish guidelines for registry-based randomized clinical trials.
Nyberg K; Hedman P
Ups J Med Sci; 2019 Jan; 124(1):33-36. PubMed ID: 30724666
[TBL] [Abstract][Full Text] [Related]
55. Whose Benchmark Is Right? Validating Venous Thromboembolism Events Between Trauma Registries and Hospital Administrative Databases.
Miano TA; Abelian G; Seamon MJ; Chreiman K; Reilly PM; Martin ND
J Am Coll Surg; 2019 May; 228(5):752-759.e3. PubMed ID: 30772443
[TBL] [Abstract][Full Text] [Related]
56. Rare disease registries: potential applications towards impact on development of new drug treatments.
Jansen-van der Weide MC; Gaasterland CMW; Roes KCB; Pontes C; Vives R; Sancho A; Nikolakopoulos S; Vermeulen E; van der Lee JH
Orphanet J Rare Dis; 2018 Sep; 13(1):154. PubMed ID: 30185208
[TBL] [Abstract][Full Text] [Related]
57. Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data.
Fitzpatrick T; Perrier L; Tricco AC; Straus SE; Jüni P; Zwarenstein M; Lix LM; Smith M; Rosella LC; Henry DA
BMJ Open; 2017 Feb; 7(2):e013770. PubMed ID: 28213601
[TBL] [Abstract][Full Text] [Related]
58. Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB).
Rubinstein YR; Groft SC; Bartek R; Brown K; Christensen RA; Collier E; Farber A; Farmer J; Ferguson JH; Forrest CB; Lockhart NC; McCurdy KR; Moore H; Pollen GB; Richesson R; Miller VR; Hull S; Vaught J
Contemp Clin Trials; 2010 Sep; 31(5):394-404. PubMed ID: 20609392
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
